Introduction to 9 19 2017 Session 1 Discussion
Exploring 9 19 2017 Session 1 Discussion reveals several interesting facts. Panelists discuss, and field questions from the audience.
9 19 2017 Session 1 Discussion Comprehensive Overview
MARK MCCLELLAN , Workshop Series Co-Chair Director Duke-Margolis Center for Health Policy. JOANNE WALDSTREICHER Chief Medical Officer Johnson&Johnson. ELEANOR PERFETTO Senior Vice President, Strategic Initiatives National Health Council.
Moderated Panel
Summary & Highlights for 9 19 2017 Session 1 Discussion
- MICHAEL SHERMAN Senior VP and Chief Medical Officer Harvard Pilgrim Health Care.
- MICHAEL HORBERG Executive Director, Research, Community Benefit, and Medicaid Strategy Executive Director, Mid-Atlantic ...
- DANIEL FORD Director, Institute for Clinical and Translational Research Johns Hopkins School of Medicine.
- Panelists discuss, and field questions from the audience.
- Andy Bindman, University of California, San Francisco.
Stay tuned for more updates related to 9 19 2017 Session 1 Discussion.